CNS Depressants: Sedative-Hypnotics - Chapter 12
Fundamentals of Central Nervous System (CNS) Depressants and Sedative-Hypnotics
General Introduction to CNS Depressants: * CNS depressants are a broad class of drugs that slow brain activity, making them useful for treating anxiety, panic, acute stress reactions, and sleep disorders. * They are categorized based on their clinical usage: * Anxiolytics: Drugs used specifically to relieve anxiety, fear, and apprehension. * Hypnotics: Drugs used to induce drowsiness and encourage sleep. * Historical Context: The history of CNS depressants traces the evolution from early, more dangerous substances like bromides and barbiturates to the modern, safer benzodiazepines. * The Problem of Categorization: Not all CNS depressants are created equal; they differ significantly in their chemical structure, potency, duration of action, and safety profile.
Essential Terminology for Sedative-Hypnotic Study
Barbiturates: A class of potent CNS depressants traditionally used as sedatives and hypnotics. Though largely replaced by safer alternatives, they remain clinically relevant for seizure control and general anesthesia.
Antihistamines: Drugs often used to treat allergies that also possess CNS-depressing properties. They are frequently used in over-the-counter (OTC) sleep aids, though they do not produce the same responses in all people.
Anxiolytic: A pharmacological agent specifically designed to reduce anxiety.
Hypnotics: From the Greek "Hypnos" (sleep), these are agents used to induce sleep or maintain sleep in patients with insomnia.
Amnesiac: A substance or effect that causes a loss of memory. In clinical settings, benzodiazepines are often used to produce amnesia during medical procedures so the patient has no memory of the unpleasant experience.
Club Drug: A category of drugs used at all-night raves, parties, dance clubs, and bars to enhance sensory experiences. Many CNS depressants, such as GHB, fall into this category.
Paradoxical Effects: An unexpected reaction to a drug that is the opposite of the intended effect (e.g., a sedative causing excitement, agitation, or hyperactivity).
Detoxification: The clinical process of safely removing a drug from a dependent individual's body while managing withdrawal symptoms.
Detailed Classification and Pharmacological Profiles
Benzodiazepines (Valium-Type Drugs): * These are currently the most popular and safest prescription CNS depressants in use. * Distinguishing Characteristics: Benzodiazepines are primarily distinguished from one another by their duration of action (short-acting vs. long-acting). * Medical Uses: Includes anxiety relief, sleep induction, treatment of convulsive disorders (anti-epileptics), and as pre-anesthetic medication for surgery. * Common Side Effects: Drowsiness, lightheadedness, and impaired motor coordination.
Barbiturates: * Older class of drugs with a narrow therapeutic index, meaning the difference between a therapeutic dose and a lethal dose is small. * Effects of Uncontrolled Use: High potential for respiratory depression, physical dependence, and fatal overdose. * Comparison: Benzodiazepines are preferred over barbiturates because they have a much higher margin of safety and a lower risk of fatal respiratory suppression.
Other CNS Depressants: * Propofol: Clinically used as a general anesthetic or for sedation during medical procedures. It is frequently abused by medical professionals due to its availability in clinical settings. * GHB (Gamma-Hydroxybutyrate): A potent CNS depressant often abused for its euphoric and sedative effects; it is frequently linked to drug-facilitated sexual assault and the club scene.
Mechanism of Action: The Role of GABA
GABA (Gamma-Aminobutyric Acid): The primary inhibitory neurotransmitter in the mammalian central nervous system.
Benzodiazepine Interaction: Benzodiazepines do not act directly on GABA receptors in isolation; rather, they serve as modulators. They bind to specific Benzodiazepine Receptors which are part of the receptor complex.
The Result of Binding: When a benzodiazepine binds to its receptor, it enhances the affinity of the receptor for GABA itself, increasing the frequency of chloride channel opening. This leads to hyperpolarization of the neuron, effectively inhibiting its ability to fire and resulting in sedation and relaxation.
Clinical Applications and Procedures
Anesthesia: * Specific CNS depressants are used to achieve a controlled state of unconsciousness. * This allows a patient to undergo surgery in relative comfort and without the memory of the trauma.
Sleep Science: * REM (Rapid Eye Movement): The restive phase of sleep associated with dreaming. Many CNS depressants can interfere with the normal sleep cycle, specifically suppressing the REM phase.
Risks, Patterns of Abuse, and Withdrawal
Why CNS Depressants are Problematic: 1. Potentiation: They have a synergistic effect when combined with other depressants (like alcohol), which can be fatal. 2. Dependence: Both physical and psychological dependence can develop rapidly. 3. Cross-Tolerance: Users can develop a tolerance to one depressant that carries over to others in the same class. 4. Withdrawal Severity: Withdrawal from CNS depressants can be more dangerous than withdrawal from narcotics, often involving life-threatening seizures.
Patterns of Abuse: * Demographics: Abuse is seen in individuals seeking to manage stress, people using them to "come down" from stimulants (like cocaine or amphetamines), and those using them to enhance the effects of alcohol or opioids. * Methods: Often involves combining pills with other substances or taking dosages far exceeding clinical recommendations.
Treatment for Withdrawal: * Withdrawal must be managed through medical detoxification. * Dangers: If a person who is severely dependent is not tapered off the drug slowly, they may experience severe tremors, hallucinations, and grand mal seizures.
Discussion of Specific Medications
Halcion (Triazolam) and Xanax (Alprazolam): * These are potent benzodiazepines known for their fast onset. * Negative Effects: Can include significant amnesia, confusion, and "rebound insomnia" (where the original sleep problem returns more severely once the drug is stopped). * Regulatory Context: There has been historical debate regarding whether the FDA should allow Halcion to remain on the market given its profile of side effects and psychiatric complaints.